A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study

BMC Cancer

Table 5 Global health status in maintenance therapy arms 1–3, and arms 2+3 versus control arm 5

Characteristic	Arm 1 (n = 46)	Arm 2 (n = 76)	Arm 3 (n = 42)	Arms 2+3 (n = 118)	Arm 5 (n = 80)
At screening
MS ± SD	77.51 ± 10.24	78.83 ± 10.35	76.97 ± 10.96	78.18 ± 10.56	78.24 ± 9.75
p*	0.6733	0.7162	0.5236	0.9690
After combined treatment
MS ± SD	63.51 ± 9.64	64.95 ± 8.65	63.52 ± 9.77	64.45 ± 9.04	63.98 ± 7.46
p*	0.7475	0.4603	0.7724	0.7085
At the end of the study
MS ± SD	55.37 ± 20.48	63.69 ± 14.88	58.23 ± 18.33	61.57 ± 16.41	53.19 ± 16.52
p*	0.6532	0.0060	0.2796	0.0240

MS mean score, SD standard deviation
*Student’s test was applied to determine the differences between arms 1–3 vs arm 5 and arms 2+3 vs arm 5
NOTE. Bold font indicates p < 0.05

ISSN: 1471-2407